低聚木糖对模拟失重大鼠肠道微生态的影响

目的 研究低聚木糖对模拟失重大鼠肠道微生态的影响。方法 采用大鼠尾部悬吊法模拟失重。32只雄性SD大鼠随机分为4组,每组8只：FC组（地面对照组,饲喂基础饲料）,FS组（地面处理组,饲喂添加低聚木糖的饲料）,SC组（尾吊对照组,饲喂基础饲料）。SS组（尾吊处理组,饲喂添加低聚木糖的饲料）,实验21d,SC和SS组解除尾吊继续观察。实验21d。采用选择性培养基对大鼠粪便肠杆菌、肠球菌、类杆菌、双歧杆菌以及乳杆菌进行定量测定。结果 SC组与FC组相比,双歧杆菌数量减少,肠杆菌和肠球菌数量增加;FS组比FC组双歧杆菌数量增加显著,肠杆菌和肠球菌有不同程度的减少,SS组比SC组双歧杆菌数量增加显著,肠杆菌和肠球菌也有不同程度的减少。类杆菌和乳杆菌变化不明显。尾吊解除期,SS组双歧杆菌数量比SC组更快恢复到正常水平。结论 低聚木糖可促进尾吊大鼠肠道益生菌主要是双歧杆菌的增殖,一定程度上促进由于模拟失重造成肠道微生态失调的平衡,并对条件致病菌具有一定的抑制作用。     

饮用加银水对模拟失重大鼠肠道微生态及骨钙代谢的影响

目的 :研究饮用加银水对模拟失重大鼠肠道微生态及骨钙代谢的影响。方法 :30只 SD雄性大鼠随机分为地面对照组 ( GC)、模拟失重对照组 ( SC)和模拟失重饮用 0 .2 0 mg/ L 加银水组 ( SS) ,实验期 2 1d。第 7、14和 2 1天用选择性培养基分别对肠球菌、肠杆菌、双歧杆菌、乳杆菌及类杆菌定量测定 ,并测定饲料钙表观吸收率 ;第 2 1天取右侧股骨测骨密度和骨钙含量。结果 :骨密度和骨钙含量 SC组显著低于 GC组 ,SS组也低于 SC组 ;SC组和 GC组比较 ,SC组出现厌氧菌群的减少和需氧菌群的增加及饲料钙表观吸收率的下降 ,且这种变化出现较早 ,SS组和 SC组比较 ,SS组出现以厌氧菌群中 G 菌的减少和需氧菌群G-菌的增加为主的菌群失调及饲料钙表观吸收率的下降 ,且这种变化出现较晚。结论 :饮用 0 .2 0 mg/ L 加银水可以加重模拟失重大鼠肠道微生态的失调和骨钙代谢的紊乱 ,但需要较长的作用时间 ,且其微生态的失调以 G 细菌减少为主的厌氧菌群减少型     

功能性低聚糖及其检测方法研究的现状

低聚糖（oligosaccharides）又称寡糖,是由2～10个单糖以直链或分支结构形成的糖类的总称。低聚糖包括普通低聚糖和功能性低聚糖（functional oligosaccharides）。普通低聚糖有蔗糖、麦芽糖、麦芽三糖等。而功能性低聚糖如低聚果糖、低聚半乳糖、大豆低聚糖、低聚异麦芽糖,是一类在人体不被消化,具有特殊生理功能,特别是有益于肠道健康的一类低聚糖,是一种功能性食品的重要基料。     

益生菌补充剂治疗绝经后骨质疏松症或骨量减少的系统评价

目的 系统评价益生菌补充剂对绝经后骨质疏松症（PMOP）或骨量减少的有效性及安全性。方法 选取8个公共数据库,检索自建库至2022年9月,无语言限制,使用随机对照方法,评估补充益生菌补充剂对腰椎、股骨颈、总髋关节骨密度（BMD)、T值（T-value）、胶原降解产物（CTX）、I型前胶原氨基端前肽（PINP）、骨碱性磷酸酶（BALP）、骨钙素（BGP）水平和不良反应率的影响。结果 纳入了8篇RCT文献,647名参与者,治疗组有325名,对照组322名。结果显示益生菌组在提高PMOP和绝经后骨量减少患者的腰椎BMD、股骨颈BMD、T值、BGP和降低绝经后妇女CTX、BALP等方面显著优于对照组（P<0.05）。亚组分析结果显示益生菌治疗PMOP患者后显著提高腰椎BMD、股骨颈BMD、全髋关节BMD、T值和降低CTX、BALP优于对照组（P<0.05）。结论 益生菌干预PMOP和骨量减少患者后显著提高骨密度及降低骨代谢,对PMOP患者的作用更显著。     

中等强度跑台运动预防去卵巢大鼠骨质疏松

目的观察中等强度跑台运动对去卵巢大鼠骨质疏松的预防作用。方法将30只3月龄未经产雌性SD大鼠随机分为假手术、去卵巢静止和去卵巢运动三个组。去卵巢运动组每周进行4次时间45min、速度18m/min、坡度5°的跑台训练。实验结束时,检测血清雌二醇（E2）、碱性磷酸酶（ALP）、抗酒石酸酸性磷酸酶（TRAP）和骨钙素（BGP）水平以及右侧游离股骨和胫骨的骨密度（BMD）和骨矿物含量（BMC）;同时观察左侧股骨远端和胫骨近端组织形态学变化。结果与假手术组比较,去卵巢静止组大鼠血清ALP活性和BGP含量显著升高,血清TRAP活性和E2含量显著下降,股骨近段和远端以及胫骨近端BMD和BMC显著下降,股骨远端和胫骨近端骨小梁断裂增加、数目减少;与去卵巢静止组比较,去卵巢运动组大鼠血清E2和BGP含量显著上升,股骨三个部位以及胫骨近端BMD和BMC显著增加,股骨远端和胫骨近端骨小梁断裂减少、数目增加。结论中等强度跑台运动能增加去卵巢大鼠血清E2和BGP含量,改善去卵巢大鼠骨组织学结构。     

蛇骨粉中活性钙在动物体内吸收和利用的研究

目的 探讨蛇骨粉中活性钙在动物体内的吸收和利用情况。方法 以蛇骨粉为钙源饲料喂养大鼠,以低钙、碳酸钙、全脂奶粉喂养大鼠作为对照;喂养大鼠28天,动物单笼饲养,自由饮水,自由进食,逐日记录饲料摄取量,每4天称重1次。实验结束前4天做代谢实验,收集粪尿。实验结束时断头取血,测血清钙、磷及碱性磷酸酶,同时采双侧股骨,剔净肌腱,测股骨中Ca、P含量,计算钙存留。结果 蛇骨粉组股骨钙的存留率、活性钙在体内的吸收率和存留率与碳酸钙和全脂奶粉组无显著性差异（P＞0.05）。结论 以蛇骨作为活性钙来源在动物体内的吸收利用较好,能有效地补充钙质。     

施普瑞螺旋藻对尾吊模拟失重大鼠肠道微生态失调的调整作用研究

目的：研究模拟失重条件下,施普瑞螺旋藻对大鼠肠道微生态失调的调整作用。方法：将基础饲料中加入5%的螺旋藻作为处理组饲喂大鼠,用选择性培养基分别对肠球菌、肠杆菌、类杆菌、乳杆菌以及双歧杆菌定量测定,扫描电镜观察大鼠盲肠上皮细胞的组织变化,结果：螺旋藻处理组过路菌群中肠杆菌和肠球菌数量变化并不明显;原籍菌群中双歧杆菌较对照组显著增多,类杆菌和乳杆菌的数量差异没有显著性,模拟失重条件下SD大鼠盲肠上皮有肿胀细胞出现,并且肠道上皮绒毛排列紊乱、稀疏、而螺旋藻处理组中只发现有少量的肿胀细胞,上皮绒毛致密,排列较整齐。结论：旋普瑞螺旋藻具有纠正在模拟失重条件下大鼠肠道微生态平衡失调的作用。     

氟骨症不同动物模型的建立与评价

目的 为选择合适的实验动物并建立氟骨症动物模型,研究不同动物对氟化物致骨骼损伤的敏感性.方法 分别选取离乳新西兰兔、Hartley豚鼠、Wistar大鼠、KM小鼠各16只,每种动物随机分为两组,每组8只,即对照组(C):饲喂标准饲料,饮用去离子水;模型组(M):饲喂标准饲料,饮用150 mg/L氟化钠(NaF)去离子水.在饲喂60 d后取股骨制作组织切片观察组织形态变化,并测定股骨骨氟、骨钙、骨磷的含量及血清碱性磷酸酶(ALP)活性.结果 与对照组相比,各种实验动物模型组生长发育受到显著的抑制,股骨形态破坏明显,骨矿化显著减少,骨氟含量显著升高,血清ALP活性显著增强,但股骨钙和磷含量差异无显著性(P＞0.05).结论 高氟可不同程度的损害豚鼠、家兔、小鼠、大鼠的生长发育及骨骼系统,导致产生氟骨症,但综合考察,以豚鼠、家兔较为敏感,其次为小鼠、大鼠.     

益生菌制剂对绝经后骨质减少女性患者骨骼状态的改善作用

摘要：目的 研究益生菌制剂对绝经后骨质减少女性患者骨骼状态的改善作用。方法 选择2016年4月—2018年4月在本院就诊的绝经女性478例,其中骨质疏松患者103例。将患者分为对照组和益生菌组,两组患者均连续治疗6个月,定期进行随访。检测患者治疗前后骨密度（BMD）、骨代谢指标、骨折情况、肠道微生物情况。结果 治疗后益生菌组患者I型胶原吡啶交联终肽（CTX）、骨特异性碱性磷酸酶（BALP）均明显低于对照组治疗后水平（CTX：P=0.004;BALP：P=0.011）和益生菌治疗前水平（CTX：P=0.008;BALP：P=0.024）。对照组治疗前后丰度排列前三位的微生物均为Bacteroides plebeius,布氏瘤胃球菌（Ruminococcus bromii）,普拉梭菌（Faecalibacterium prausnitzii）;益生菌组治疗前后丰度排列前三位的微生物均为Bacteroides plebeius,普拉梭菌（Faecalibacterium prausnitzii）,布氏瘤胃球菌（Ruminococcus bromii）。结果显示益生菌组患者治疗后肠道甲醇拟无枝酸菌（Amycolatopsis methanolica）,Burkholderia oklahomensis,Streptomyces turgidiscabies,Verrucosispora maris检出率明显低于治疗前（P=0.009,0.012,0.005,0.007）。结论 益生菌可以改善骨代谢,对绝经后骨质减少女性具有骨保护作用,其机制可能与益生菌对肠道微生物分布的影响有关。     

几种益生元制剂对肠道菌群作用效果的研究

目的探讨几种益生元制剂对肠道菌群作用效果。方法通过体外实验和体内试验。结果低聚果糖、水苏糖、低聚木糖、低聚异麦芽糖均能促进双歧杆菌和乳杆菌的增殖,并能够酸化肠道的pH;能够显著提高肠道的B／E值（肠道内双歧杆菌和肠杆菌数量log值的比值）,增加肠道中有益菌的比例,有益于稳定肠道的微生态平衡。结论这几种益生元制剂对肠道菌群有较好的调节作用。     

Effect of low or high dietary calcium on the morphology of the rat femur

The present study compared the effect of a calcium deficit or surfeit on femurs. Young female rats were fed with the normal (1.18%), low (0.05%), or high (2.00%) calcium diet for 3, 7, 15 or 30 days. Two groups received the low calcium diet for the first 15 days and then were followed by the normal (L-N) or high calcium diets (L-H) for the sequential 15 days. The morphology of the femur was studied together with serum calcium, parathyroid hormone (PTH), calcitonin and bone mineral density (BMD). We did not find any significant changes in the serum PTH level and bone morphology in the high calcium group. In the low calcium group, the serum PTH level increased, BMD of the whole body, the femoral weight and the femoral trabecular bone decreased as compared with the normal calcium group. There was a greater proportion of resorbing surface, less resting surface and larger vascular canal openings in the femoral endosteal surfaces in the low calcium group. In the L-N or L-H group, the femoral trabecular bone increased and the femoral resorbing surface decreased as compared with those of the low calcium group. These findings suggest that high calcium intakes do not affect the bone mass, and low calcium intakes have a deleterious effect on bone status, which may be related to vascular alternations of the bone. Reversing the low income calcium intake by a higher calcium diet can partially improve the bone alternations induced by low calcium intake.     

Milk calcium taken with cheese increases bone mineral density and bone strength in growing rats

We investigated the calcium bioavailability of milk calcium, taken with or without cheese. Twenty-four 6-week-old male rats for a meal-feeding experiment were trained to consume an AIN-76 diet within 2 h (2 times per day) for 2 weeks. The rats were then divided into three experimental groups, each fed 2 types of experimental diets: Control group, Cheese group, and Ca-Cheese group. The rats were each alternately given 2 types of experimental diets at 2-h meal-feeding for 31 days. The breaking force and energy of the femur in the Ca-Cheese group were significantly higher than in the control group. The bone mineral density (BMD) of the lumbar spine and the femur in the Ca-Cheese group was also significantly higher than in the other two groups. These results indicate that milk calcium taken with cheese increases bone strength and BMD efficiently, results that may be useful for the prevention of osteoporosis.     

Prolonged increase in dietary phosphate intake alters bone mineralization in adult male rats

Excessive intake of dietary phosphate without the company of calcium causes serum parathyroid hormone (s-PTH) concentration to rise. We investigated the effect of a modest but prolonged increase in dietary intake of inorganic phosphate on the bone quantitative factors of mature male rats. Twenty Wistar rats were divided into two groups and fed a high-phosphate diet (1.2% phosphate) or a control diet (0.6% phosphate) for 8 weeks. In the beginning and at the end of the study period, femur and lumbar bone mineral density (BMD), bone mineral content and area were measured using DXA, s-PTH was analyzed from the blood sample, and after sacrifice, right femur was cut loose and processed into paraffin cuts. Bone diameter, inner diameter and cortical width was measured from the hematoxylin- and eosin-dyed femur cuts. Tibias were degraded and calcium and phosphate content was analyzed by inductively coupled plasma-mass spectrometer. Femoral BMD increased significantly more in the control group than in the phosphate group (P=.005). Lumbar BMD values decreased in both groups, and the fall was greater in the control group (P=.007). The phosphate group had significantly higher s-PTH values (P=.0135). Femoral histomorphometric values or tibial mineral contents did not differ between groups. In conclusion, increase in dietary phosphate intake caused s-PTH to rise and hindered mineral deposition into cortical bone, leading to lower BMD. The effect on trabecular bone was opposing as mineral loss was less in the lumbar spine of phosphate group animals. These results are in concurrence with the data stating that skeletal response to PTH is complex and site dependent.     

Effects of vitamin K2 administration on calcium balance and bone mass in young rats fed normal or low calcium diet

OBJECTIVE: The purpose of this study was to examine the effects of vitamin K2 administration on calcium balance and bone mass in young rats fed a normal or low calcium diet. METHODS: Forty female Sprague-Dawley rats, 6 weeks of age, were randomized by stratified weight method into four groups with 10 rats in each group: 0.5% (normal) calcium diet, 0.1% (low) calcium diet, 0.5% calcium diet + vitamin K2 (menatetrenone, 30 mg/100 g chow diet), and 0.1% calcium diet + vitamin K2. After 10 weeks of feeding, serum calcium and calciotropic hormone levels were measured, and intestinal calcium absorption and renal calcium reabsorption were evaluated. Bone histomorphometric analyses were performed on cortical bone of the tibial shaft and cancellous bone of the proximal tibia. RESULTS: Feeding a low calcium diet induced hypocalcemia, increased serum parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D [1,25(OH)2D] levels with decreased serum 25-hydrovyvitamin D [25(OH)D] level, stimulated intestinal calcium absorption and renal calcium reabsorption, and reduced cortical bone mass as a result of decreased periosteal bone gain and enlarged marrow cavity, but did not significantly influence cancellous bone mass. Vitamin K2 administration in rats fed a low calcium diet stimulated renal calcium reabsorption, retarded the abnormal elevation of serum PTH level, increased cancellous bone mass, and retarded cortical bone loss, while vitamin K2 administration in rats fed a normal calcium diet stimulated intestinal calcium absorption by increasing serum 1,25(OH)2D level, and increased cortical bone mass. CONCLUSION: This study clearly shows the differential response of calcium balance and bone mass to vitamin K2 administration in rats fed a normal or low calcium diet.     

Moderate/subclinical calcium deficiency attenuates trabecular mass,microarchitecture and bone growth in growing rats

Adequate dietary calcium (Ca) intake is essential for bone accretion, peak bone mass (PBM) attainment, bone quality and strength during the mammalian growth period. Severe Ca deficiency during growing age results in secondary hyperparathyroidism (SHPT) and poor bone quality and strength. However, the impact of moderate Ca deficiency during rats early growth period on bone health and the reversibility with supplementing calcium later in adult life remains unclear. Female Sprague-Dawley (SD) rats (postnatal 28th day, P28) were initiated either with a moderate calcium-deficient diet (MCD, 0.25% w/w Ca) or a control diet (0.8% w/w Ca, control group) till P70. Thereafter, MCD rats were continued either with MCD diet or supplemented with calcium diet (0.8% w/w Ca, calcium supplemented group, CaS) till P150. Another group (control rats) were fed 0.8% w/w Ca containing diet from P28 till P150.MCD group, as compared to the control group, had significantly reduced serum ionized Ca and procollagen type 1 N-terminal propeptide (P1NP) at P70 while no significant change was observed in serum corrected Ca, inorganic phosphate (P), alkaline phosphatase (ALP), 25-hydroxy vitamin D [25(OH)D], intact parathyroid hormone (iPTH), and urinary C-terminal telopeptide of collagen 1 (CTX-1), Ca, and P. Femoral and tibial metaphysis in MCD rats had significantly reduced linear growth, cortical and trabecular volumetric BMD (vBMD), trabecular microarchitecture (BV/TV%, trabecular thickness, separation and number, structural model index and connectivity density), cortical thickness, and bone stiffness despite the absence of secondary hyperparathyroidism (SHPT). Continued MCD at P70–P150 results in persistence of compromised bone strength while calcium supplementation (CaS group) improved all the parameters related to bone strength and microarchitecture. Our results indicate that uncorrected moderate/subclinical calcium deficiency in growing rats can result in poor bone quality and strength despite the absence of SHPT. This finding could have relevance in children with poor calcium intake in childhood and adolescence.     

Effects of vitamin D supplementation on calcium balance and bone growth in young rats fed normal or low calcium diet

OBJECTIVE: We examined the effect of vitamin D supplementation on bone growth in young rats fed a normal or low calcium diet. METHODS: Fifty female Sprague-Dawley rats, 6 weeks of age, were randomized by stratified weight method into five groups with 10 rats in each group: baseline control, 0.5% (normal) or 0.1% (low) calcium diet, and 0.5 or 0.1% calcium diet + vitamin D (25 microg/100 g, food intake). Duration of the experiment was 10 weeks. RESULTS: Vitamin D supplementation stimulated intestinal calcium absorption and increased urinary calcium excretion in rats fed a low or normal calcium diet. Vitamin D supplementation prevented the reduction in periosteal bone gain but enhanced enlargement of the marrow cavity and reduced the maturation-related cancellous bone gain in rats fed a low calcium diet, and increased the maturation-related cancellous and cortical bone gains in rats fed a normal calcium diet. CONCLUSION: This study shows the differential effects of vitamin D supplementation on born growth in young rats fed a normal or low calcium diet.     

Flaxseed oil and inflammation-associated bone abnormalities in interleukin-10 knockout mice

Interleukin-10-/- (IL-10) knockout (KO) mice develop an intestinal inflammation that closely mimics human inflammatory bowel disease (IBD) which is accompanied by inflammation-associated bone abnormalities and elevated serum proinflammatory cytokines. The objective of this study was to use the IL-10 KO mouse model to determine whether flaxseed oil (FO) diet, rich in alpha-linolenic acid (ALA), attenuates intestinal inflammation and inflammation-associated bone abnormalities, compared to a corn oil (CO) control diet. Male wild-type (WT) or IL-10 KO mice were fed a 10% CO or 10% FO diet from weaning (postnatal day 28) for 9 weeks. At necropsy, serum, intestine, femurs and lumbar vertebrae were collected and analyzed. IL-10 KO mice fed CO had lower femur bone mineral content (BMC; P<.001), bone mineral density (BMD; P<.001), peak load (P=.033) and lumbar vertebrae BMD (P=.02) compared to WT mice fed either diet. Flaxseed oil had a modest, favorable effect on IL-10 KO mice as femur BMC, BMD and peak load were similar to WT mice fed CO or FO. In addition, lumbar vertebra BMD was similar among IL-10 KO mice fed FO and WT mice fed CO or FO. The fact that FO attenuated serum tumor necrosis factor-alpha (TNF-alpha) among IL-10 KO mice suggests that the positive effects of FO on femur BMC, BMD, peak load and vertebral BMD in IL-10 KO mice may have been partly mediated by changes in serum TNF-alpha. In conclusion, these findings suggest that a dietary level of ALA attainable from a 10% flaxseed oil diet results in modest improvements in some bone outcomes but does not attenuate intestinal inflammation that is characteristic of IL-10 KO mice.     

Enhancing effect of dietary vinegar on the intestinal absorption of calcium in ovariectomized rats.

We studied the effect of dietary vinegar on calcium absorption by using ovariectomized rats fed on a low-calcium diet. The apparent absorption of calcium was higher when the rats were fed on a diet containing 1.6% vinegar for 32 days than when fed on a diet without vinegar (P < 0.05). The calcium content in the femur of the rats given diets containing 0.4% and 1.6% vinegar were also higher (P < 0.05). The serum parathyroid hormone level was lower and the crypt depth of the duodenum thicker in the rats fed on a diet containing 1.6% vinegar (P < 0.05). These results suggest that dietary vinegar enhanced intestinal calcium absorption by improving calcium solubility and by the trophic effect of the acetic acid contained in vinegar, which would reduce the bone turnover caused by ovariectomy and be helpful in preventing osteoporosis.     

Changes of femoral alkaline phosphatase activity in adult rats treated by sorbitol enriched or vitamin D3 deficient diet

The effect of vitamin D3-deficiency and dietary sorbitol on serum calcium level, the activity and alkaline phosphatase (AP) pattern in femoral epiphysis were studied. Rats fed a diet supplemented with sorbitol or vitamin D3 showed the same serum calcium concentration and AP activity in serum and femur. Rats fed a vitamin D3-deficient diet displayed decreased serum calcium concentration and increased AP activity both in serum and femur. Four forms of AP were isolated from the femur of these rat groups: of Mr 100,000, 110,000, 130,000 and 165,000. Rats receiving the diet supplemented with sorbitol showed a marked rise in the activity of the Mr 165,000 form, and appearance of a new monomer of 100,000, never formed in two remaining groups.